NCT05093322 2024-06-07A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid TumorsHutchmedPhase 1/2 Completed13 enrolled 17 charts
NCT02511132 2022-12-22A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's SarcomaGradalis, Inc.Phase 2 Completed22 enrolled 13 charts